These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2677242

  • 41. A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep.
    Ramaekers JG, van Veggel LM, O'Hanlon JF.
    Clin Neuropharmacol; 1994; 17 Suppl 1():S9-18. PubMed ID: 7954488
    [Abstract] [Full Text] [Related]

  • 42. Regional action of brofaromine on rat brain MAO-A and MAO-B.
    Gerardy J, Dresse A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1141-55. PubMed ID: 9829294
    [Abstract] [Full Text] [Related]

  • 43. Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
    Finberg JP.
    Acta Psychiatr Scand Suppl; 1995 Oct; 386():8-13. PubMed ID: 7717096
    [Abstract] [Full Text] [Related]

  • 44. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
    Cusson JR, Goldenberg E, Larochelle P.
    J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
    [Abstract] [Full Text] [Related]

  • 45. The current status of monoamine oxidase and its inhibitors.
    Jarrott B, Vajda FJ.
    Med J Aust; 1987 Jun 15; 146(12):634-8. PubMed ID: 3114597
    [Abstract] [Full Text] [Related]

  • 46. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
    Oxenkrug GF, Requintina PJ, Yuwiler A.
    J Neural Transm Suppl; 1990 Jun 15; 32():171-5. PubMed ID: 2089086
    [Abstract] [Full Text] [Related]

  • 47. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.
    Colzi A, d'Agostini F, Cesura AM, Da Prada M.
    Psychopharmacology (Berl); 1992 Jun 15; 106 Suppl():S17-20. PubMed ID: 1546133
    [Abstract] [Full Text] [Related]

  • 48. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.
    Cesura AM, Kettler R, Imhof R, Da Prada M.
    Psychopharmacology (Berl); 1992 Jun 15; 106 Suppl():S15-6. PubMed ID: 1546132
    [Abstract] [Full Text] [Related]

  • 49. The effects of single and repeated administration of MAO inhibitors on acoustic startle response in rats.
    Zajaczkowski W, Górka Z.
    Pol J Pharmacol; 1993 Jun 15; 45(2):157-66. PubMed ID: 8401768
    [Abstract] [Full Text] [Related]

  • 50. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 Jun 15; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 51. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 15; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 52. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P, Langley RW, Tavernor S, Pyykkö K, Scheinin M, Szabadi E, Bradshaw CM.
    Br J Clin Pharmacol; 1998 Jun 15; 45(6):551-8. PubMed ID: 9663810
    [Abstract] [Full Text] [Related]

  • 53. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    Koulu M, Scheinin M, Kaarttinen A, Kallio J, Pyykkö K, Vuorinen J, Zimmer RH.
    Br J Clin Pharmacol; 1989 Feb 15; 27(2):243-55. PubMed ID: 2469451
    [Abstract] [Full Text] [Related]

  • 54. From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.
    Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Saura Marti J, Muggli-Maniglio D, Wyss PC, Kyburz E, Imhof R.
    J Neural Transm Suppl; 1990 Feb 15; 29():279-92. PubMed ID: 2193111
    [Abstract] [Full Text] [Related]

  • 55. Brofaromine: a monoamine oxidase-A and serotonin uptake inhibitor.
    Waldmeier PC, Glatt A, Jaekel J, Bittiger H.
    Clin Neuropharmacol; 1993 Feb 15; 16 Suppl 2():S19-24. PubMed ID: 8313393
    [Abstract] [Full Text] [Related]

  • 56. Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.
    Waldmeier PC, Graf T, Germer M, Feldtrauer JJ, Howald H.
    Biol Psychiatry; 1993 Mar 01; 33(5):373-9. PubMed ID: 8471696
    [Abstract] [Full Text] [Related]

  • 57. Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristics.
    Cesura AM, Muggli-Maniglio D, Lang G, Imhof R, Da Prada M.
    J Neural Transm Suppl; 1990 Mar 01; 32():165-70. PubMed ID: 2089085
    [Abstract] [Full Text] [Related]

  • 58. The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats.
    Celada P, Bel N, Artigas F.
    J Neural Transm Suppl; 1994 Mar 01; 41():357-63. PubMed ID: 7931251
    [Abstract] [Full Text] [Related]

  • 59. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.
    Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH.
    Int J Neuropsychopharmacol; 2015 Aug 27; 19(1):. PubMed ID: 26316187
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
    Simpson GM, Gratz SS.
    Clin Pharmacol Ther; 1992 Sep 27; 52(3):286-91. PubMed ID: 1526086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.